Ptc Therapeutics (PTCT) Treasury Shares (2012)

Ptc Therapeutics' Treasury Shares history runs 15 years deep, the most recent figure standing at $3.5 million for Q2 2026.

• In Q2 2026, Treasury Shares fell 7.76% year-over-year to $3.5 million; the TTM figure through Jun 2026 stood at $3.5 million (down 7.76% YoY), while the FY2025 annual figure was $3.7 million, up 3.96% from the prior year.
• Treasury Shares for Q2 2026 stood at $3.5 million, down from $3.6 million in the prior quarter.
• The five-year high for Treasury Shares was $3.9 million in Q1 2025, with the low at $2.5 million in Q3 2022.
• The 5-year median for Treasury Shares is $3.6 million (2024), against an average of $3.4 million.
• The sharpest annual moves came in 2022 and 2026: Treasury Shares soared 68.27% in 2022, then decreased 7.76% in 2026.
• Ptc Therapeutics' Treasury Shares stood at $2.5 million in 2022, then advanced by 13.91% to $2.9 million in 2023, then gained by 23.07% to $3.5 million in 2024, then gained by 3.96% to $3.7 million in 2025, then declined by 3.95% to $3.5 million in 2026.
• Business Quant data shows PTCT's Treasury Shares at $3.5 million in Q2 2026, $3.6 million in Q1 2026, and $3.7 million in Q4 2025.